Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Reprod ; 24(5): 1045-50, 2009 May.
Article in English | MEDLINE | ID: mdl-19189994

ABSTRACT

Infertility patients are known to be at increased risk of endometrial carcinoma (EC) and atypical hyperplasia (AH). However, the incidence and clinical features of EC and AH in these patients remain to be clarified. In this study, we examined the rate at which a routine infertility workup revealed EC/AH and investigated the clinicopathological features of EC/AH detected in this way. Among patients diagnosed with EC or AH at the Jichi Medical University Hospital between the 10-year period from 1997 to 2006, six patients were referred from Tochigi Central Clinic, a specialized infertility facility. We report the clinicopathological features of these patients and calculate the incidence of EC/AH in patients who underwent infertility investigations at Tochigi Central Clinic. All six patients were younger than 40 and had early stage disease (final diagnosis: EC stage IA: 3, EC stage IB: 1, AH: 2). A total of 19 826 patients underwent routine infertility investigations at Tochigi Central Clinic during the same period. The incidence of EC/AH detected from these investigations was 0.03% (6/19 826) and that of EC was 0.02% (4/19 826): 5-10 times higher than the overall incidence in Japanese women of the same age. Routine infertility investigations may provide an opportunity to examine the corpus uteri of young women in whom examination is otherwise limited, contributing to the early detection of EC/AH.


Subject(s)
Endometrial Hyperplasia/epidemiology , Endometrial Neoplasms/epidemiology , Infertility, Female/complications , Adult , Endometrial Hyperplasia/complications , Endometrial Hyperplasia/diagnosis , Endometrial Neoplasms/complications , Endometrial Neoplasms/diagnosis , Female , Humans , Incidence , Middle Aged , Retrospective Studies
2.
Cells Tissues Organs ; 171(2-3): 199-214, 2002.
Article in English | MEDLINE | ID: mdl-12097842

ABSTRACT

Decorin is a small leucine-rich proteoglycan suspected of playing an important role in tissue morphogenesis. However, its role in the development of skeletal muscle is less clear. In the present study, the expression and spatial distribution of decorin in developing skeletal muscle of bovine fetuses were investigated, in order to provide a background for understanding the function of decorin in morphogenesis of the intramuscular connective tissue that supports muscle fibres. Western blot analysis showed that decorin already existed in skeletal muscle by 2.5 months of fetal development, and that decorin had a longer glycosaminoglycan chain in the early fetal stages than in later development, but its core protein was of the same size. Decorin mRNA was expressed at 1 month of fetal development, although its level was relatively low. Indirect immunofluorescence microscopy demonstrated that decorin was located in the perimysium which consisted of collagen fibres, but not in the endomysium which was composed of collagen fibril networks in fetal skeletal muscle. The relatively integrated structure of the perimysium had already formed by 2.5 months of fetal development, when muscle fibres were not tightly assembled and the surrounding endomysium was not well organized. These results suggest that decorin contributes to the formation and stabilization of collagen fibres in the perimysium that support muscle fibres assembled with myogenesis.


Subject(s)
Connective Tissue/growth & development , Muscle Development , Muscle, Skeletal/growth & development , Proteoglycans/metabolism , Animals , Cattle , Decorin , Extracellular Matrix Proteins , Fetus/physiology , Fetus/ultrastructure , Immunohistochemistry , Morphogenesis , Muscle Fibers, Skeletal/physiology , Muscle Fibers, Skeletal/ultrastructure , Muscle, Skeletal/metabolism , Muscle, Skeletal/ultrastructure , Proteoglycans/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
3.
Int J Androl ; 24(2): 102-8, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11298844

ABSTRACT

This study was performed to investigate if unexpectedly poor fertilization and in-vitro fertilization (IVF) outcome could be predicted using sperm morphology as diagnosed by the strict criteria. Sperm morphology was assessed in 137 IVF-ET cycles with at least three oocytes collected. The lowest amount of normal forms was 5% in 137 samples, indicating there were no patients belonging to 'poor prognosis' (<5% normal forms). Treatment using intracytoplasmic sperm injection (ICSI) was also excluded. Before sperm separation by the swim-up method, sperm morphology demonstrated a significant correlation with the fertilization rate (p < 0.0001). The fertilization rate (80.5%) in 110 'normal' samples (>14% normal forms) was significantly higher (p < 0.01) than that (55.4%) in 27 samples with 'good prognosis' (those with 5--14% normal forms). No embryo was available for transfer (ET) in 4 (3.6%) of 110 'normal' cycles and in 3 (11.1%) of 27 'good prognosis' cycles (not significant). Fresh ET was intentionally cancelled to avoid severe ovarian hyperstimulation syndrome (OHSS) in six of 110 'normal' cycles as well as in one of 27 'good prognosis' cycles. The pregnancy rate per ET was 31.0% (31/100) in the former group, while it was 26.1% (6/23) in the latter group. There was no difference between the two groups. In the post swim-up evaluation of sperm characteristics, morphology was significantly correlated with the fertilization rate in IVF-ET (p < 0.05) while other sperm parameters were not. When the cut off level for the post swim-up sperm morphology was set at 25%, there was a significant difference in the fertilization rates between patients (78.6%) with post-swim-up >25% and those (55.0%) with post-swim-up < or =25% (p < 0.01). Taken together, a relative indication for ICSI using sperm morphology before and after swim-up was established. Category A includes < or =14% normal forms in the ejaculate and post-swim-up < or =25%, while Category B includes < or =14% in the ejaculate and post-swim-up >25%. There was a significant difference in the fertilization rates between patients (47.2%) in Category A and those (60.2%) in Category B (p < 0.05). The clinical pregnancy rate was 11.1% for patients in Category A compared with 35.7% for patients in Category B. However, there was no significant difference between the two categories. These results indicate that the strict criteria provide a reliable estimation of the fertilizing ability of human spermatozoa. ICSI might be considered in Category A patients to avoid poor fertilization and pregnancy outcome.


Subject(s)
Fertilization/physiology , Pregnancy Outcome , Spermatozoa/physiology , Cell Separation , Embryo Implantation , Female , Fertilization in Vitro , Humans , Male , Predictive Value of Tests , Pregnancy , Sperm Injections, Intracytoplasmic , Spermatozoa/cytology
4.
J Vet Med Sci ; 61(10): 1119-23, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10563289

ABSTRACT

A wasting disease characterized by progressive weight loss and dyspnea has been observed in weaning pigs on a farm in Yamagata Prefecture in 1998. Histopathologic findings in an affected pig were bronchointerstitial pneumonia and intracytoplasmic clusters of basophilic inclusions in macrophages of lymph nodes, which were similar to those in pigs with postweaning multisystemic wasting syndrome (PMWS) recently reported in North America and Europe. Porcine circovirus (PCV)-like particles were observed in bronchial lymph node of the pig by electron microscopy, and PCV antigens were detected in the lesions by immunohistochemical staining. PCV DNA was also detected in the lung and tonsil by PCR, and restriction fragment length polymorphism analysis of the PCR products with HinfI showed the same type of the PCV associated with PMWS (pmws PCV). Homology of nucleotide sequences between the PCR product and corresponding regions of published pmws PCV genomes was very high. These results indicated that virus detected in this study was pmws PCV. To our knowledge, this is the first report on the presence of pmws PCV in Japan.


Subject(s)
Circoviridae Infections/veterinary , Circovirus/isolation & purification , Swine Diseases/virology , Wasting Syndrome/veterinary , Amino Acid Sequence , Animals , Circoviridae Infections/pathology , Circoviridae Infections/virology , Circovirus/chemistry , Circovirus/genetics , DNA, Viral/isolation & purification , Deoxyribonucleases, Type II Site-Specific/chemistry , Electrophoresis, Agar Gel/veterinary , Immunohistochemistry , Inclusion Bodies, Viral/ultrastructure , Lymph Nodes/ultrastructure , Microscopy, Electron/veterinary , Molecular Sequence Data , Polymerase Chain Reaction/veterinary , Polymorphism, Restriction Fragment Length , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Swine , Swine Diseases/pathology , Wasting Syndrome/pathology , Wasting Syndrome/virology
5.
J Vet Med Sci ; 59(2): 129-32, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9070986

ABSTRACT

Endectocidal efficacy of doramectin administered intramuscularly at a dosage of 300 micrograms/kg was evaluated in 464 pigs naturally infected with intestinal nematodes or mange mites on 14 commercial farms in Japan. By doramectin treatment, fecal egg counts were reduced > 99% for Ascaris suum, Strongyloides ransomi, Oesophagostomum dentatum, and Trichuris suis; worm counts of T. suis and mite counts of Sarcoptes scabiei reduced 90.1% on Day 21 and 99.5% on Day 28 following treatment, respectively.


Subject(s)
Anthelmintics/therapeutic use , Intestinal Diseases, Parasitic/veterinary , Ivermectin/analogs & derivatives , Nematode Infections/veterinary , Scabies/veterinary , Swine Diseases/drug therapy , Animals , Anthelmintics/administration & dosage , Ascariasis/drug therapy , Ascariasis/veterinary , Ascaris suum/isolation & purification , Feces/parasitology , Female , Injections, Intravenous/veterinary , Intestinal Diseases, Parasitic/drug therapy , Ivermectin/administration & dosage , Ivermectin/therapeutic use , Nematode Infections/drug therapy , Oesophagostomiasis/drug therapy , Oesophagostomiasis/veterinary , Oesophagostomum/isolation & purification , Parasite Egg Count/veterinary , Scabies/drug therapy , Skin/parasitology , Strongyloides/isolation & purification , Strongyloidiasis/drug therapy , Strongyloidiasis/veterinary , Swine , Time Factors , Trichuriasis/drug therapy , Trichuriasis/veterinary , Trichuris/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...